SCHEMBL29623271

SCHEMBL29623271

COc1cccc(CN(C)c2cc(-c3ccco3)nc(N)n2)c1

nearest known ligand 0.61

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 11/20 0.58
ADORA1 P30542 8/20 0.58
ADORA3 P0DMS8 5/20 0.58
ADORA2B P29275 5/20 0.58
ALDH1A1 P00352 3/20 0.48
USP2 O75604 2/20 0.48
TP53 P04637 2/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 2/20 0.48
CYP2D6 P10635 2/20 0.48
CYP2C19 P33261 2/20 0.48
HSD17B10 Q99714 2/20 0.48
CLK4 Q9HAZ1 2/20 0.48
LMNA P02545 1/20 0.48
GLA P06280 1/20 0.48
ALOX15 P16050 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.43
PTGS1 P23219 1/20 0.42
PTGS2 P35354 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23162575 0.76 ADORA2A (0.51) ADORA2AADORA1ADORA3ADORA2BALDH1A1
SCHEMBL930823 0.73 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL7092230 0.71 ALDH1A1 (0.51) ADORA2AADORA1ADORA3ADORA2BALDH1A1
SCHEMBL30353576 0.70 ALDH1A1 (0.58) ADORA2AADORA1ADORA3ADORA2BALDH1A1
SCHEMBL1554000 0.69 MAPT (0.58) ADORA2AADORA1ADORA3ADORA2BALDH1A1
SCHEMBL3268210 0.67 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL4456961 0.65 ADORA2A (1.00) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL929118 0.65 ADORA2A (0.63) ADORA2AADORA1ADORA3ADORA2B
SCHEMBL30353595 0.65 ADORA2A (0.50) ADORA2AADORA1ADORA3ADORA2BALDH1A1
SCHEMBL28736302 0.65 SMN1; SMN2 (0.71) ADORA2AALDH1A1CYP2D6SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4038065-A1 SUBSTITUTED PYRIMIDINE FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2022-08-10 EP disclosed
CN-114450277-A Substituted pyrimidines for the treatment and prevention of hepatitis B virus infection 豪夫迈·罗氏有限公司 2022-05-06 CN disclosed